Global Care Products market

Market development

eCommerce revenue development in the global Medical Products market

The global Medical Products eCommerce market is expected to decrease over the next years. It is predicted to reach US$20,777.1 million by 2024 and the expected compound annual growth rate for the next four years (CAGR 2024-2028) will be -0.7%. The Medical Products eCommerce market is a sub-market of the Health Care market and accounts for 14.1% within this market. Further categories within the Health Care market are: Eye Care, Nutrition, Other Health Care, and Pharmaceuticals.

eCommerce revenue development in the global Medical Products market

in million US$

eCommerce revenue growth in the global Medical Products market

in %
20202021202220232024202520262027
Revenue (in mUS$)0.00.00.00.00.00.00.00.0
Growth (in %)94.672.560.275.646.671.921.324.3

Online share

eCommerce online share of the total Medical Products market

The online share refers to the proportion of the retail volume that is transacted via the Internet. It includes purchases via desktop PC, tablet or smartphone, both via website or app. Only retail of physical goods is taken into account. In the global Medical Products retail market, the online share is 30.9% and will increase by an average of 4.9% to 37.4% by 2028.

eCommerce online share of the total Medical Products market

in %
20202021202220232024202520262027
Online share (in %)14.2%54.3%12.7%46.9%17.7%17.0%64.7%30.3%

Market definition

Definition of the Medical Products market within the Care Products market

Market definition: Care Products > Health Care > Medical Products The category Medical Products includes the online trade of medical supplies (e.g. mobility aids, orthopedic supports) and family planning (e.g. contraceptives, fertility and ovulation tracking). This category does not cover pharmaceuticals. All monetary figures refer to the annual gross revenue and do not factor in shipping costs.

In-scope

  • Medical supplies (e.g. mobility aids, orthopedic supports)
  • Family planning (e.g. contraceptives, fertility and ovulation tracking)

Out-of-scope

  • Pharmaceuticals